相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tardive dyskinesia: motor system impairments, cognition and everyday functioning
Martin Strassnig et al.
CNS SPECTRUMS (2018)
Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis
Maren Carbon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol
A. Parabiaghi et al.
ACTA PSYCHIATRICA SCANDINAVICA (2016)
Dose Equivalents for Antipsychotic Drugs: The DDD Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2016)
Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study
Gerhard Gruender et al.
LANCET PSYCHIATRY (2016)
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
P. Manu et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies
Pal Czobor et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia
Dieter Naber et al.
SCHIZOPHRENIA RESEARCH (2015)
Incidence of Tardive Dyskinesia in Older Adult Patients Treated With Olanzapine or Conventional Antipsychotics
Bruce J. Kinon et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2015)
Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia A Randomized Clinical Trial
Joseph P. McEvoy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: A pragmatic, randomized trial
E. Johnsen et al.
EUROPEAN PSYCHIATRY (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Treatment of neurolept-induced tardive dyskinesia
Stacey K. Jankelowitz
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2013)
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs
Michael J. Peluso et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study
Leslie Citrome et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
Robert W. Buchanan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons
Peter M. Haddad et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial
Ragy R. Girgis et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder
K. N. Roy Chengappa et al.
ACTA NEUROPSYCHIATRICA (2010)
Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications: A Prospective Cohort Study
Scott W. Woods et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
Wolfgang Gaebel et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
J. Schoemaker et al.
PHARMACOPSYCHIATRY (2010)
A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia
Herbert Y. Meltzer et al.
PSYCHIATRY RESEARCH (2010)
How to read and understand and use systematic reviews and meta-analyses
S. Leucht et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis
Manuel J. Cuesta et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
A Comparison of Ziprasidone and Risperidone in the Long-Term Treatment of Schizophrenia: A 44-Week, Double-Blind, Continuation Study
Donald E. Addington et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2009)
Olanzapine compared to quetiapine in adolescents with a first psychotic episode
Celso Arango et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2009)
Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol
Steven G. Potkin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Extrapyramidal side-effects of antipsychotics in a randomised trial
Del D. Miller et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Metoclopramide, an increasingly recognized cause of tardive dyskinesia
Christopher Kenney et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder:: an open randomised clinical trial
Rene S. Kahn et al.
LANCET (2008)
Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial
Peter Tyrer et al.
LANCET (2008)
Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: A post hoc analysis
Del D. Miller et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia:: 1-Year results of a randomized controlled trial within the German research network on schizophrenia
Wolfgang Gaebel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder - Randomised, controlled, open-label study
Nicholas A. Keks et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia
Shon W. Lewis et al.
SCHIZOPHRENIA BULLETIN (2006)
Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning
Bruce J. Kinon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Olanzapine and haloperidol in first episode psychosis: Two-year data
A. I. Green et al.
SCHIZOPHRENIA RESEARCH (2006)
A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms
BJ Kinon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia
RSE Keefe et al.
SCHIZOPHRENIA RESEARCH (2006)
Olanzapine versus ziprasidone: Results of a 28-week double-blind study in patients with schizophrenia
A Breier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Effects of antipsychotic treatment on tardive dyskinesia: A 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
DE Tenback et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder
ID Glick et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia
MRK Dossenbach et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies
CU Correll et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
The prevalence of Tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders
JDJ Mari et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2004)
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes
SR Marder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Olanzapine versus divalproex in the treatment of acute mania
M Tohen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia
SR Hirsch et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Tardive dyskinesia associated with metoclopramide in persons with developmental disabilities
JL Matson et al.
RESEARCH IN DEVELOPMENTAL DISABILITIES (2002)
Atypical antipsychotics: Mechanism of action
P Seeman
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2002)
Amisulpride, an unusual atypical antipsychotic: A meta-analysis of randomized controlled trials
S Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia
JG Csernansky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine
GD Tollefson et al.
BIOLOGICAL PSYCHIATRY (2001)
Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia:: results of a multicentre, double-blind study (the Amisulpride Study Group)
P Carrière et al.
EUROPEAN PSYCHIATRY (2000)
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
SE Purdon et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia
L Colonna et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2000)
分享论文
